VanEck Uranium & Nuclear ETF (NLR) Stock Price Today
Key Stats
- -Market Cap
- -Volume
- Sector/ThematicSector
- $164.3752W High
- $102.7052W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track VanEck Uranium & Nuclear ETF (NLR) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, VanEck Uranium & Nuclear ETF has traded between a low of $102.7 and a high of $164.37, highlighting its annual price range. Buy and sell VanEck Uranium & Nuclear ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About VanEck Uranium & Nuclear ETF
VanEck Uranium and Nuclear ETF seeks exposure to companies involved in uranium mining and the nuclear power industry. Its holdings may include miners, utilities, reactor-related companies, and nuclear equipment or service providers.
Most Recent News
BMO downgrades Lululemon to Underperform amid legal probe and weak sales outlook
BMO Capital Markets initiated coverage of Lululemon Athletica with an Underperform rating and a $70 price target, citing weakening demand in key markets and margin pressures. This follows a 4% revenue decline in Q2 and a reduced full-year forecast. M...

Hycroft Mining reports high-grade silver and gold drill results at Vortex and Brimstone zones in Nevada.
Hycroft Mining announced strong drill results from its 2025-2026 exploration program at the Hycroft Mine in Nevada, revealing high-grade silver and gold mineralization in the Vortex and Brimstone zones. Key intercepts include 30.5 meters at 780.53 g/...

DecisionDx-SCC test improves risk prediction and treatment guidance for high-risk skin cancer patients.
Castle Biosciences announced a study validating the enhanced DecisionDx-SCC test, which integrates genetic and clinical risk factors to better predict metastasis and local recurrence in high-risk cutaneous squamous cell carcinoma (SCC) patients. The ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.